Leverage Next Generation Technologies to Define Size, Cargo & Surface Markers to Demonstrate Consistency & Reproducibility for Quality Confidence

Welcome to the Exosome Characterization & Analytical Development Summit

Empower Exosome Analysis: Accuracy, Standardization, Consistency & Reliability for Regulatory Promise

 

https://exosome-analytical-development.com/wp-content/uploads/sites/927/2023/12/cropped-Favicon-2.png
https://exosome-analytical-development.com/wp-content/uploads/sites/927/2023/12/cropped-Favicon-2.png
https://exosome-analytical-development.com/wp-content/uploads/sites/927/2023/12/cropped-Favicon-2.png
https://exosome-analytical-development.com/wp-content/uploads/sites/927/2023/12/cropped-Favicon-2.png

1 preconference focus day to hone in on solutions to improve your pipeline progression

1 preconference focus day to hone in on solutions to improve your pipeline progression

18+ key speakers sharing new solutions and data

Join 60+ of your peers to have your burning questions on characterization and analytical technologies answered

Join this comprehensive summit to unite with biopharma and academic experts in characterization techniques and analytical technologies.

In the ever-evolving exosome field, the past year has witnessed remarkable progress, making the growing need for standardization of techniques and technologies increase. Meeting regulatory needs presents a challenge, highlighting the growing importance of developing resilient techniques. These techniques serve as the cornerstone for exosome therapeutics, complementing advancements in drug delivery applications. 

The Exosome Characterization & Analytical Development Summit offers a comprehensive forum, equipping you with the skills needed to establish robust techniques, select the best instruments, ensure quality, and seamlessly navigate regulatory processes. 

Expert speakers from Rion Therapeutics, Harvard Medical School, Astellas, AbbVie, and many others will be preparing exclusive presentations of recent case studies and data to inform you about what is to come in the exosome field. Network to ask your burning questions, aid your decision-making, and ultimately progress your pipelines. 

Companies On The Program:

astellas
abbvie
EV Therapeutics: Immunotherapy EVolved.
EXO Biologics
Shift Bio
Vesigen Therapeutics
Harvard Medical School
George Mason University
Aegle Therapeutics
OmniSpirant Therapeutics

World-Class Speaker Faculty Includes:

Testimonials From Previous Attendees Of The Exosome Series

“I appreciate the calibre of attendees and speakers at Hanson Wade conferences, and this was no exception. Very good group and topics.”
Director

APC

“It was really a great opportunity to share common knowledge and experience with other people in our field and Network.”
Principle Research Scientist

Exocel Bio

Our 2024 Partners

NanoFCM
Roosterbio logo

Other Events In The Series